(Q43584700)

English

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial (English)

1 reference

Europe PubMed Central

24 November 2017

Adaptive radiation therapy

0 references

author name string

Jeremic B

1

1 reference

Europe PubMed Central

24 November 2017

Shibamoto Y

2

1 reference

Europe PubMed Central

24 November 2017

Acimovic L

3

1 reference

Europe PubMed Central

24 November 2017

Milicic B

4

1 reference

Europe PubMed Central

24 November 2017

Milisavljevic S

5

1 reference

Europe PubMed Central

24 November 2017

Nikolic N

6

1 reference

Europe PubMed Central

24 November 2017

Dagovic A

7

1 reference

Europe PubMed Central

24 November 2017

Aleksandrovic J

8

1 reference

Europe PubMed Central

24 November 2017

Radosavljevic-Asic G

9

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

24 November 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

24 November 2017

50

1 reference

Europe PubMed Central

24 November 2017

1

1 reference

Europe PubMed Central

24 November 2017

19-25

1 reference

Europe PubMed Central

24 November 2017

Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tables of the number of patients required in clinical trials using the logrank test.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-sm

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation for non-small cell lung cancer using conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901546-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)01546-7

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43584700&oldid=2101679255"